Earnings ·
TriMas reports Q3 adjusted EPS of $0.50 on $178.7M sales and signs deal to sell Rapak
TRSTrimas Corp
TriMas reported third-quarter net sales of $178.7 million, a 7.7% increase year-over-year, driven by organic growth in its Packaging and Specialty Products segments. Adjusted diluted earnings per share rose 194.1% to $0.50 from $0.17 in the prior year period, supported by interest income on its substantial cash balance and cost-reduction initiatives. The company also announced it signed an agreement to sell its Rapak flexible bag-in-box product line for approximately $20 million, with the transaction expected to close in November 2026. TriMas reaffirmed its full-year adjusted EPS outlook of $1.60 to $1.70 and expects sales growth of 4% to 6%. The company operates in the consumer packaging, life sciences, and industrial markets through its Packaging and Specialty Products groups.